{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T16:41:27Z","timestamp":1775666487276,"version":"3.50.1"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100008349","name":"Boehringer Ingelheim","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008349","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","resmedjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Medicine"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.rmed.2024.107881","type":"journal-article","created":{"date-parts":[[2024,11,22]],"date-time":"2024-11-22T16:13:25Z","timestamp":1732292005000},"page":"107881","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Factors associated with uncontrolled severe asthma in the biologic era"],"prefix":"10.1016","volume":"236","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7134-3364","authenticated-orcid":false,"given":"Hideki","family":"Yasui","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1086-4393","authenticated-orcid":false,"given":"Kyohei","family":"Oishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fumiya","family":"Nihashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4079-5509","authenticated-orcid":false,"given":"Kazuki","family":"Furuhashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8809-1781","authenticated-orcid":false,"given":"Tomoyuki","family":"Fujisawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yusuke","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masato","family":"Karayama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5439-1543","authenticated-orcid":false,"given":"Hironao","family":"Hozumi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6154-9791","authenticated-orcid":false,"given":"Yuzo","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3187-4264","authenticated-orcid":false,"given":"Noriyuki","family":"Enomoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suguru","family":"Kojima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsuru","family":"Niwa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masanori","family":"Harada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masato","family":"Kato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dai","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koshi","family":"Yokomura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoki","family":"Koshimizu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mikio","family":"Toyoshima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9043-881X","authenticated-orcid":false,"given":"Masahiro","family":"Shirai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshihiro","family":"Shirai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoki","family":"Inui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takafumi","family":"Suda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"10258","key":"10.1016\/j.rmed.2024.107881_bib1","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/S0140-6736(20)30925-9","article-title":"Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019","volume":"396","author":"Diseases","year":"2020","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.rmed.2024.107881_bib2","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.alit.2020.08.001","article-title":"A. Japanese Society of, Japanese guidelines for adult asthma 2020","volume":"69","author":"Nakamura","year":"2020","journal-title":"Allergol. Int."},{"issue":"1","key":"10.1016\/j.rmed.2024.107881_bib3","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1164\/rccm.202109-2205PP","article-title":"Global initiative for asthma strategy 2021: executive summary and rationale for key changes","volume":"205","author":"Reddel","year":"2022","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"2","key":"10.1016\/j.rmed.2024.107881_bib4","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1183\/09031936.00202013","article-title":"International ERS\/ATS guidelines on definition, evaluation and treatment of severe asthma","volume":"43","author":"Chung","year":"2014","journal-title":"Eur. Respir. J."},{"issue":"1","key":"10.1016\/j.rmed.2024.107881_bib5","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.alit.2019.06.003","article-title":"Prevalence, disease burden, and treatment reality of patients with severe, uncontrolled asthma in Japan","volume":"69","author":"Nagase","year":"2020","journal-title":"Allergol. Int."},{"issue":"2","key":"10.1016\/j.rmed.2024.107881_bib6","doi-asserted-by":"crossref","first-page":"124","DOI":"10.3109\/02770900903518835","article-title":"Factors associated with the control of severe asthma","volume":"47","author":"Hermosa","year":"2010","journal-title":"J. Asthma"},{"issue":"4","key":"10.1016\/j.rmed.2024.107881_bib7","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/j.chest.2019.10.053","article-title":"Characterization of severe asthma worldwide: data from the international severe asthma registry","volume":"157","author":"Wang","year":"2020","journal-title":"Chest"},{"issue":"4","key":"10.1016\/j.rmed.2024.107881_bib8","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.resinv.2021.02.003","article-title":"The association between control level and self-reported treatment adherence across different treatment types in Japanese asthma patients","volume":"59","author":"Gon","year":"2021","journal-title":"Respir. Investig."},{"issue":"2","key":"10.1016\/j.rmed.2024.107881_bib9","first-page":"74","article-title":"Direct health care costs associated with asthma in British Columbia","volume":"17","author":"Sadatsafavi","year":"2010","journal-title":"Cancer Res. J."},{"issue":"4","key":"10.1016\/j.rmed.2024.107881_bib10","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1034\/j.1399-3003.1999.14d29.x","article-title":"Development and validation of a questionnaire to measure asthma control","volume":"14","author":"Juniper","year":"1999","journal-title":"Eur. Respir. J."},{"issue":"10423","key":"10.1016\/j.rmed.2024.107881_bib11","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0140-6736(23)02284-5","article-title":"Reduction of daily maintenance inhaled corticosteroids in patients with severe eosinophilic asthma treated with benralizumab (SHAMAL): a randomised, multicentre, open-label, phase 4 study","volume":"403","author":"Jackson","year":"2024","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.rmed.2024.107881_bib12","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.jaci.2011.11.017","article-title":"The role of the small airways in the clinical expression of asthma in adults","volume":"129","author":"Farah","year":"2012","journal-title":"J. Allergy Clin. Immunol."},{"issue":"9","key":"10.1016\/j.rmed.2024.107881_bib13","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1111\/all.13850","article-title":"The clinical benefit of mepolizumab replacing omalizumab in uncontrolled severe eosinophilic asthma","volume":"74","author":"Chapman","year":"2019","journal-title":"Allergy"},{"issue":"12","key":"10.1016\/j.rmed.2024.107881_bib14","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1111\/j.1365-2222.2009.03332.x","article-title":"Association between asthma control and bronchial hyperresponsiveness and airways inflammation: a cross-sectional study in daily practice","volume":"39","author":"Quaedvlieg","year":"2009","journal-title":"Clin. Exp. Allergy"},{"issue":"15","key":"10.1016\/j.rmed.2024.107881_bib15","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1056\/NEJM199010113231505","article-title":"Eosinophilic inflammation in asthma","volume":"323","author":"Bousquet","year":"1990","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.rmed.2024.107881_bib16","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1016\/j.jaci.2010.02.008","article-title":"Institute Severe Asthma Research, Analyses of asthma severity phenotypes and inflammatory proteins in subjects stratified by sputum granulocytes","volume":"125","author":"Hastie","year":"2010","journal-title":"J. Allergy Clin. Immunol."},{"issue":"1","key":"10.1016\/j.rmed.2024.107881_bib17","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.jaci.2020.01.039","article-title":"Baseline sputum eosinophil + neutrophil subgroups' clinical characteristics and longitudinal trajectories for NHLBI Severe Asthma Research Program (SARP 3) cohort","volume":"146","author":"Hastie","year":"2020","journal-title":"J. Allergy Clin. Immunol."},{"issue":"6","key":"10.1016\/j.rmed.2024.107881_bib18","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1016\/j.jaci.2013.10.011","article-title":"Sputum neutrophil counts are associated with more severe asthma phenotypes using cluster analysis","volume":"133","author":"Moore","year":"2014","journal-title":"J. Allergy Clin. Immunol."},{"issue":"12","key":"10.1016\/j.rmed.2024.107881_bib19","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/j.it.2017.07.003","article-title":"Neutrophilic inflammation in asthma and association with disease severity","volume":"38","author":"Ray","year":"2017","journal-title":"Trends Immunol."},{"issue":"5","key":"10.1016\/j.rmed.2024.107881_bib20","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1136\/thx.2008.103069","article-title":"Heterogeneity of asthma according to blood inflammatory patterns","volume":"64","author":"Nadif","year":"2009","journal-title":"Thorax"},{"key":"10.1016\/j.rmed.2024.107881_bib21","doi-asserted-by":"crossref","DOI":"10.1155\/2023\/9943584","article-title":"Dupilumab efficacy in patients with type 2 asthma with and without elevated blood neutrophils","volume":"2023","author":"Bleecker","year":"2023","journal-title":"J. Immunol. Res."},{"issue":"1","key":"10.1016\/j.rmed.2024.107881_bib22","article-title":"Blood neutrophil count is associated with body mass index in adolescents with asthma","volume":"3","author":"Rhee","year":"2018","journal-title":"JSM Allergy Asthma"},{"issue":"13","key":"10.1016\/j.rmed.2024.107881_bib23","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1056\/NEJMoa1403290","article-title":"Mepolizumab treatment in patients with severe eosinophilic asthma","volume":"371","author":"Ortega","year":"2014","journal-title":"N. Engl. J. Med."},{"issue":"10056","key":"10.1016\/j.rmed.2024.107881_bib24","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1016\/S0140-6736(16)31324-1","article-title":"Efficacy and safety of benralizumab for patients with severe asthma uncontrolled with high-dosage inhaled corticosteroids and long-acting beta(2)-agonists (SIROCCO): a randomised, multicentre, placebo-controlled phase 3 trial","volume":"388","author":"Bleecker","year":"2016","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.rmed.2024.107881_bib25","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1164\/rccm.201208-1414OC","article-title":"Exploring the effects of omalizumab in allergic asthma: an analysis of biomarkers in the EXTRA study","volume":"187","author":"Hanania","year":"2013","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"1","key":"10.1016\/j.rmed.2024.107881_bib26","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.alit.2022.11.008","article-title":"Biologics for severe asthma: the real-world evidence, effectiveness of switching, and prediction factors for the efficacy","volume":"72","author":"Nagase","year":"2023","journal-title":"Allergol. Int."},{"issue":"8","key":"10.1016\/j.rmed.2024.107881_bib28","doi-asserted-by":"crossref","first-page":"e70","DOI":"10.1164\/rccm.201908-1590ST","article-title":"Standardization of spirometry 2019 update. An official American thoracic society and European respiratory society technical statement","volume":"200","author":"Graham","year":"2019","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"4","key":"10.1016\/j.rmed.2024.107881_bib29","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.resinv.2014.03.003","article-title":"Pulmonary Functions Committee of the Japanese Respiratory, Reference values for spirometry, including vital capacity, in Japanese adults calculated with the LMS method and compared with previous values","volume":"52","author":"Kubota","year":"2014","journal-title":"Respir. Investig."},{"issue":"3","key":"10.1016\/j.rmed.2024.107881_bib30","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1016\/j.chest.2021.04.013","article-title":"Eosinophilic and noneosinophilic asthma: an expert consensus framework to characterize phenotypes in a global real-life severe asthma cohort","volume":"160","author":"Heaney","year":"2021","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.rmed.2024.107881_bib31","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1513\/AnnalsATS.201701-065OC","article-title":"Distinct phenotypes of smokers with fixed airflow limitation identified by cluster analysis of severe asthma","volume":"15","author":"Konno","year":"2018","journal-title":"Ann Am Thorac Soc"},{"issue":"1","key":"10.1016\/j.rmed.2024.107881_bib32","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.alit.2020.06.002","article-title":"Clinical characteristics of patients with not well-controlled severe asthma in Japan: analysis of the Keio Severe Asthma Research Program in Japanese population (KEIO-SARP) registry","volume":"70","author":"Tanosaki","year":"2021","journal-title":"Allergol. Int."},{"issue":"1","key":"10.1016\/j.rmed.2024.107881_bib33","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.alit.2022.06.002","article-title":"Classifications of moderate to severe asthma phenotypes in Japan and analysis of serum biomarkers: a Nationwide Cohort Study in Japan (NHOM Asthma Study)","volume":"72","author":"Suzukawa","year":"2023","journal-title":"Allergol. Int."},{"issue":"12","key":"10.1016\/j.rmed.2024.107881_bib34","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1080\/03007995.2018.1505352","article-title":"Systematic literature review of the clinical, humanistic, and economic burden associated with asthma uncontrolled by GINA Steps 4 or 5 treatment","volume":"34","author":"Chen","year":"2018","journal-title":"Curr. Med. Res. Opin."},{"issue":"1","key":"10.1016\/j.rmed.2024.107881_bib36","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00588-2019","article-title":"Management of severe asthma: a European respiratory society\/American thoracic society guideline","volume":"55","author":"Holguin","year":"2020","journal-title":"Eur. Respir. J."},{"issue":"3","key":"10.1016\/j.rmed.2024.107881_bib37","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.jaip.2022.11.025","article-title":"Association between blood eosinophils and neutrophils with clinical features in adult-onset asthma","volume":"11","author":"Flinkman","year":"2023","journal-title":"J. Allergy Clin. Immunol. Pract."},{"issue":"4","key":"10.1016\/j.rmed.2024.107881_bib38","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1183\/13993003.00336-2016","article-title":"Blood granulocyte patterns as predictors of asthma phenotypes in adults from the EGEA study","volume":"48","author":"Nadif","year":"2016","journal-title":"Eur. Respir. J."},{"issue":"6","key":"10.1016\/j.rmed.2024.107881_bib39","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1111\/cea.13378","article-title":"Severe asthma-A population study perspective","volume":"49","author":"Backman","year":"2019","journal-title":"Clin. Exp. Allergy"},{"issue":"3","key":"10.1016\/j.rmed.2024.107881_bib40","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/j.jaip.2020.09.063","article-title":"Chronic rhinosinusitis with nasal polyps and asthma","volume":"9","author":"Laidlaw","year":"2021","journal-title":"J. Allergy Clin. Immunol. Pract."},{"issue":"8","key":"10.1016\/j.rmed.2024.107881_bib41","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1111\/resp.12838","article-title":"Comorbidities in difficult asthma are independent risk factors for frequent exacerbations, poor control and diminished quality of life","volume":"21","author":"Tay","year":"2016","journal-title":"Respirology"},{"issue":"4","key":"10.1016\/j.rmed.2024.107881_bib42","article-title":"Chronic rhinosinusitis with nasal polyps and allergic rhinitis as different multimorbid treatable traits in asthma","volume":"2","author":"Castillo","year":"2023","journal-title":"J Allergy Clin Immunol Glob"},{"issue":"3","key":"10.1016\/j.rmed.2024.107881_bib43","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1164\/rccm.202305-0808OC","article-title":"Association between T2-related comorbidities and effectiveness of biologics in severe asthma","volume":"209","author":"Wechsler","year":"2024","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"6","key":"10.1016\/j.rmed.2024.107881_bib44","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00819-2023","article-title":"Clinical remission in severe asthma with biologic therapy: an analysis from the UK Severe Asthma Registry","volume":"62","author":"McDowell","year":"2023","journal-title":"Eur. Respir. J."}],"container-title":["Respiratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611124003561?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611124003561?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,6]],"date-time":"2025-02-06T22:01:11Z","timestamp":1738879271000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0954611124003561"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":42,"alternative-id":["S0954611124003561"],"URL":"https:\/\/doi.org\/10.1016\/j.rmed.2024.107881","relation":{},"ISSN":["0954-6111"],"issn-type":[{"value":"0954-6111","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Factors associated with uncontrolled severe asthma in the biologic era","name":"articletitle","label":"Article Title"},{"value":"Respiratory Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rmed.2024.107881","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"107881"}}